<html>
<head>PUBMED IDs for PRAL</head>
<body bgcolor='#C5F0F2'><h1>PRAL</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8474430/'>Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.</a> April 1  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/9538136/'>Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes.</a> June 6  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/12817001/'>A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein.</a> June 21  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/21149604/'>A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.</a> February 15  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23796246/'>Naturally-occurring dimers of flavonoids as anticarcinogens.</a> March 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26663434/'>Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.</a> July 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27188525/'>Structure-function characterization of the human mitochondrial thiamin pyrophosphate transporter (hMTPPT; SLC25A19): Important roles for Ile(33), Ser(34), Asp(37), His(137) and Lys(291).</a> May 18  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27569205/'>Emerging role of lncRNA in cancer: a potential avenue in molecular medicine.</a> August 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28396580/'>P53 Regulation-Association Long Non-Coding RNA (LncRNA PRAL) Inhibits Cell Proliferation by Regulation of P53 in Human Lung Cancer.</a> June 24  2017<br></body></html>
